FAP and neoplasm: Studies have shown that Shichuan Hu et al. constructed fibroblast activating protein-alpha (FAP) genetically engineered tumor cell-derived exosome-like vesicle vaccine (eNVs-FAP) inhibits tumor growth by reprogramming the tumor microenvironment and promoting tumor ferroptosis [167].